These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1259466)

  • 1. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. V. Vasoconstriction phaenomenon and tachyphylaxis after repeated steroid application (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):51-6. PubMed ID: 1259466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. IV. Time slope of vasoconstriction and reactive vasodilatation (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):43-50. PubMed ID: 1259465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of reflex photometric determinations of vasoconstriction after topical steroid application. Tachyphylaxis, relative and absolute refractory phase after single and multiple application of steroid.
    Altmeyer P; Cremer C
    Arch Dermatol Res (1975); 1977 Jan; 257(3):281-5. PubMed ID: 836076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cutaneous vasoconstriction test in man as a means of evaluating topical corticoids. II. Cutaneous vasoconstrictive effects of topical corticoids in tests devised by various investigators (author's transl)].
    Lutz U; Weirich EG
    Dermatologica; 1974; 148(3):160-74. PubMed ID: 4836957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
    Altmeyer P; Zaun H
    Arch Dermatol Forsch; 1974; 250(4):381-8. PubMed ID: 4447379
    [No Abstract]   [Full Text] [Related]  

  • 7. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
    Singh G; Singh PK
    Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. II. Influence of solvents (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Forsch; 1974 Feb; 248(4):387-90. PubMed ID: 4834644
    [No Abstract]   [Full Text] [Related]  

  • 10. [An optoelectronic method for the evaluation of the cutaneous vasoconstriction and vasodilatation after topical application of different ointments (author's transl)].
    Blazek V; Wienert V
    Biomed Tech (Berl); 1980 Oct; 25(10):261-8. PubMed ID: 7448297
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.
    Woodford R; Haigh JM; Barry BW
    Dermatologica; 1983; 166(3):136-40. PubMed ID: 6852325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachyphylaxis to the action of topically applied corticosteroids.
    du Vivier A; Stoughton RB
    Arch Dermatol; 1975 May; 111(5):581-3. PubMed ID: 1130802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity.
    Marks R; Sawyer M
    Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Clin Exp Dermatol; 1983 Sep; 8(5):489-93. PubMed ID: 6641007
    [No Abstract]   [Full Text] [Related]  

  • 16. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasoconstrictor activities and bio-availabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen; clinical implications.
    Barry BW; Woodford R
    Br J Dermatol; 1977 Nov; 97(5):555-60. PubMed ID: 588468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute tolerance to effects of topical glucocorticosteroids.
    Vivier AD; Stoughton RB
    Br J Dermatol; 1976 Mar; 94 suppl 12():25-32. PubMed ID: 1268076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.
    Miller JJ; Roling D; Margolis D; Guzzo C
    J Am Acad Dermatol; 1999 Oct; 41(4):546-9. PubMed ID: 10495373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.